CD80 / Janelia Fluor 646 / IDEC-114 (Galiximab)

Product Details
Supplier Novus Biologicals, a Bio-Techne brand
Catalog #: NBP2-81100JF646 (View supplier product page)
Size 0.1 ml
Price $519.00
Antigen CD80
Clone IDEC-114 (Galiximab)
Host Rabbit
Isotype IgG λ
Conjugate Janelia Fluor 646
Target Species Human
Applications WB, FC, ELISA, IHC
Description Galiximab is a primatized mAb which consists of human constant and primate (cynomolgus macaque) variable regions and binds specifically to B7-1/CD80. B7-1/CD80 is a surface glycoprotein and a member of the B7 family of costimulatory molecules. B7-1/CD80 antigen regulates T cell activation (through interacting with CD28 or CD152) and is expressed transiently in antigen-presenting cells, T cells and normal B cells, and expressed consitutively on various subtypes of B-cell lymphomas.
About CD80 and Janelia Fluor 646
CD80 The protein encoded by this gene is a membrane receptor that is activated by the binding of CD28 or CTLA-4. The activated protein induces T-cell proliferation and cytokine production. This protein can act as a receptor for adenovirus subgroup B and may play a role in lupus neuropathy. [provided by RefSeq, Aug 2011]
Janelia Fluor 646 Janelia Fluor® 646 was developed at the Janelia Campus of the Howard Hughes Medical Institute but is commercialized by other vendors. The Janelia Fluor®s family is unique in that the fluorophores are cell-permeable and are available in photoactivatable forms. These fluorophores were developed for super-resolution microscopy (STED, PALM and STORM) and live-cell microscopy in the HaloTag and SNAP-tag versions. Janelia Fluor® 646 has an excitation peak at 646 nm and an emission peak at 664 nm.
Citations
Additional
Sources
Reviews & Ratings
Submit a Review

Janelia Fluor 646 Excitation and Emission Spectra